SUBSCRIBE
SUBSCRIBE
News   Policy

GlaxoSmithKline (JOBS) Seeks to Overturn Genentech (South SF) (JOBS) Antibody Patent

October 9, 2009 | 
1 min read
Bookmark and Share

Reuters -- GlaxoSmithKline has challenged a biotech patent held by Roche's Genentech unit in a bid to give a clear run to its experimental cancer and arthritis drug Arzerra, being developed with Genmab (GEN.CO).
Legal
Genentech, Inc. GlaxoSmithKline
MORE ON THIS TOPIC
FDA
Leaked MAHA Strategy Emphasizes Vaccine Overhaul, Streamlined Access to Novel Therapies
August 18, 2025
 · 
3 min read
 · 
Heather McKenzie
Department of Homeland Security (DHS) Secretary Kristi Noem tours the National Biodefense Analysis and Countermeasures Cetner with Health and Human Services Secretary Robert F. Kennedy, Jr. and U.S. Senator Rand Paul on Fort Detrick, Maryland, June 16, 2025. (DHS photo by Tia Dufour)
Vaccines
Kennedy Revives Childhood Vaccines Safety Group, Led by NIH’s Bhattacharya
August 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Health and Human Services Secretary Robert F. Kennedy Jr. speaks while President Donald Trump looks on
Vaccines
After Scrapping mRNA Contracts, Kennedy Says mRNA Vaccines ‘May Be Very Effective’ for Cancer
August 15, 2025
 · 
2 min read
 · 
Tristan Manalac
US Dollar coin and EU currencies on weighing scale against Unated States and European Union flags as symbol of trade war, economic conflict. Selective focus on Dollar.
Drug pricing
Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy
August 14, 2025
 · 
3 min read
 · 
Annalee Armstrong